ENTITY
Keymed Biosciences

Keymed Biosciences (2162 HK)

63
Analysis
Health CareHong Kong
Keymed Biosciences Inc. operates a biotechnology company. The Company focus on the in-house discovery and development of innovative biological therapies. Keymed Biosciences provides services in China.
more
Refresh
15 Nov 2023 08:55

Keymed Biosciences (2162.HK) - Looking Forward to the Next Leap in Valuation

It's hard for Keymed's share price to rise significantly on its own unless there's an uptick in the entire biotech sector as a whole. Valuation...

Logo
324 Views
Share
30 May 2023 08:55

Keymed Biosciences (2162.HK) - Behind the Plunge in Share Price and the Outlook

The share price plunge shows there's either a low-level mistake or "other issues", which may have a negative impact on the whole ecology of HKEX....

Logo
356 Views
Share
08 May 2024 10:09

Sichuan Kelun-Biotech Biopharm (6990.HK) - Once the Products Hit the Market, Good Story May Stop

Kelun Bio seeks to raise HKD540.5M in net proceeds from Share Placement. The Placing Price is HKD150/share (6.8% discount to Last Traded Price of...

Logo
774 Views
Share
16 Apr 2024 23:56

[Blue Lotus Healthcare Sector Update]: Bottom-Fishing at the Bottom of the Business Cycle

​Liquidity crises in healthcare innovation present buying opportunity;PD-1 exceeds expectations with 20%YoY growth forecast for 2024;Biosimilars...

Share
18 Mar 2024 08:55

Important New Policy for China’s Innovative Drugs – The Game Rule Is About to Change Radically

A new document about China's innovative drugs would change the game rule/outlook radically. We have reasons to start being optimistic that the...

Logo
291 Views
Share
x